Modifying effect of obesity on the content of sex hormones and their receptors in endometrial adenocarcinoma and its surrounding tissue
Автор: Kit O.I., Frantsiyants E.M., Bandovkina V.A., Moiseenko T.I., Chernikova N.V., Adamyan M.L., Poryvaev Y.A., Cheryarina N.D., Tumanyan S.V., Kornienko S.V.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 21, 2022 года.
Бесплатный доступ
To study the effect of comorbid pathology: obesity of degree 2-3 on the level of sex steroid hormones and their receptors in the tumor and its surrounding tissue in patients with endometrial cancer (EC). Materials and methods. In 30 patients with endometrioid adenocarcinoma T1-3N0-1M0 (the main group, 15 females with obesity grade 2-3 (BMI≥35); the reference group 15 females with normal BMI) in samples of the tumor and its perifocal zone taken after surgical treatment, the levels of estradiol (E2), estrone (E1), testosterone (T), progesterone (P4), androgen receptors (AR), progesterone receptors (RP4), estrogen receptors (ERα and ERβ) were determined by ELISA method. Statistical analysis was performed with STATISTICA 10.0. Results. Obese EC patients showed longer healing of postoperative wounds, slow recovery, and more frequent tumor metastasizing to regional lymph nodes. In the tumor samples in all patients, compared with the intact endometrium, the levels of estrogens, testosterone and their receptors were higher. Obesity accompanying the malignant process led to a local increase in the levels of estrogens, testosterone, progesterone and AR, ERα and ERβ in the tumor. In the tumor samples, there were no significant differences from the presence of obesity in the levels of RP4. In the perifocal zone of the tumor in patients with comorbid pathology, compared with the parameters in the reference group, the level of E2, P4 and T was also higher, but the content of all steroid receptors was lower. Conclusion. Obesity aggravates hyperestrogenism and progesterone deficiency in adenocarcinoma and increases its enrichment with the androgen and estrogen receptors with the prevalence of ERα over ERβ that may cause the autocrine-paracrine regulation of the growth and metastasizing of the malignant process in patients with endometrial cancer.
Endometrial cancer, obesity, estrogens, progesterone, testosterone, steroid hormone receptors
Короткий адрес: https://sciup.org/148324177
IDR: 148324177
Список литературы Modifying effect of obesity on the content of sex hormones and their receptors in endometrial adenocarcinoma and its surrounding tissue
- Masuda T, et al. A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. Cancer Sci. 2020;111(12):4646-4651. doi: 10.1111/cas.14667.
- Kit OI, et al. Changes in the expression of estrogen- regulatory genes during malignancy of the tissues of the uterine body. Kuban Scientific Medical Bulletin. 2016; 2: 84-90. [in Russian]
- Guskova NK, et al. The level of sex hormones and the severity of hyperplastic processes in the genital tract in women with chronic chlamydial infection. South Russian Journal of Cancer. 2020;1(1):23-31. https://doi.org/10.37748/2687-0533-2020-1-1-2
- Nagai K, Hayashi K, Yasui T. Disease history and risk of comorbidity in women’s life course: a comprehensive analysis of the Japan Nurses’ Health Study baseline survey. BMJ Open. 2015;5(3):e006360
- Kho PF, et al. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. Int J Cancer. 2021;148(2):307-319. doi: 10.1002/ijc.33206.
- Aune D, et al. Anthropometric factors and endometrial cancer risk: A systematic review and dose-response meta-analysis of prospective studies. Ann Oncol. 2015; 6:1635–48.
- Painter JN, O’Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, Dennis J AOCS Group; for RENDOCAS; National Study of Endometrial Cancer Genetics Group (NSECG); Australian National Endometrial Cancer Study Group (ANECS).Cancer Epidemiol Biomarkers Prev. 2016; 25(11):1503-1510. doi: 10.1158/1055-9965.EPI-16-0147.
- Harvey I, Boudreau A, Stephens JM. Adipose tissue in health and disease. Open Biol. 2020;10(12):200291. doi: 10.1098/rsob.200291.
- Kiesel L, et al. Obesity Epidemic-The Underestimated Risk of Endometrial Cancer. Cancers (Basel). 2020;12(12):3860. doi: 10.3390/cancers12123860.
- Pavone D, et al. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3‐11
- Yang HP, et al. Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2013;177:142–51.
- Hari Kumar KVS. The good, the bad, and the ugly facets of insulin resistance. Med J Armed Forces India. 2020;76:4–7. doi: 10.1016/j.mjafi.2019.07.001
- Mu N, et al. Therapeutic effect of metformin in the treatment of endometrial cancer. Oncol Lett. 2020;20(5):156. doi: 10.3892/ol.2020.12017.
- Wiwatpanit T, et al. Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome. J Clin Endocrinol Metab. 2020;105(3):769-80. doi: 10.1210/clinem/dgz100
- Gibson DA, Simitsidellis I, Collins F, Saunders PTK. Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders. Int J Mol Sci. 2018;19(10):3276. doi: 10.3390/ijms19103276.
- Frantsyants EM, et al. Hormonal profile of melanoma and surrounding tissues. Molecular medicine. 2014;6:48-51. [in Russian]
- Bandovkina VA, Frantsyants EM, Pogorelova YuA, Cheryarina ND. Peculiarities of steroidogenesis in the tumor and surrounding tissues in experimental melanoma. Molecular Medicine. 2015; 5:47-51. [in Russian]
- Frantsyants E.M. et al. Influence of chronic neurogenic pain on the receptor status of the skin and the tumor growing in it in female mice with transplanted B16/F10 melanoma. Medical Bulletin of the North Caucasus. 2019;14:1-2:250-5. [in Russian]
- Foster PA. Steroid Sulphatase and Its Inhibitors: Past, Present, and Future.Molecules. 2021;26(10):2852. doi: 10.3390/molecules26102852.
- Wan J, et al. The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer. Sci Rep. 2016;6:39744. doi: 10.1038/srep39744.
- van Weelden WJ, et al. Anti-estrogen treatment in endometrial cancer: A systematic review. Front Oncol. 2019; 9:359. doi: 10.3389/fonc.2019.00359.
- Comim FV, Hardy K, Franks S. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One 2013;8:e80416
- Simitsidellis I, Saunders PTK, Gibson DA. Androgens and endometrium: new insights and new targets. Mol Cell Endocrinol. 2018;465:48–60.
- Perrone AM, et al. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. J Sex Med. 2009;6(11):3193–200.
- Simitsidellis I, et al. A role for androgens in epithelial proliferation and formation of glands in the mouse uterus. Endocrinology. 2016;157(5):2116–28.
- Abu Shahin N, et al. Differential Expression of Androgen Receptor in Type I and Type II Endometrial Carcinomas: A Clinicopathological Analysis and Correlation with Outcome. Oman Med J. 2021;36(2):e245. doi: 10.5001/omj.2021.53.
- Kamal AM, et al. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival. Br. J. Cancer. 2016;114:688–96. doi: 10.1038/bjc.2016.16.
- Babayev SN, et al. Androgens Upregulate Endometrial Epithelial Progesterone Receptor Expression: Potential Implications for Endometriosis.Reprod Sci. 2017;24(10):1454-61. doi: 10.1177/1933719117691145.